Innovative Clinical Trials in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
Innovative Clinical Trials in Colombia
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Innovative Clinical Trials in Colombia

Inovative Clinical Trials in Colombia – top CROs in Latin America

Innovative Clinical Trials in Colombia

Clinical trials serve as the cornerstone of medical advancements, offering new hope and improved treatments for patients. In recent years, Colombia has emerged as a leading destination for innovative clinical trials, attracting domestic and international researchers.

This article explores the thriving landscape of clinical trials in Colombia, highlighting the country’s commitment to cutting-edge research and its potential to revolutionize healthcare.

From groundbreaking therapies to patient-centric approaches, Colombia is fostering an environment conducive to scientific exploration, making significant contributions to medical knowledge, and transforming the lives of patients worldwide.

Advancements in Therapeutic Areas

Colombia’s clinical trial industry has witnessed remarkable advancements across various therapeutic areas, driving medical breakthroughs in fields such as oncology, neurology, cardiology, infectious diseases, and regenerative medicine.

Innovative treatments, including targeted therapies, immunotherapies, gene therapies, and stem cell therapies, are being tested in Colombia, offering new possibilities for patients who previously had limited treatment options. These trials not only expand the treatment landscape but also pave the way for personalized medicine, tailoring therapies to individual patient needs.

Colombia’s commitment to research excellence, state-of-the-art infrastructure, and collaborative efforts between researchers, healthcare providers, and pharmaceutical companies have played a significant role in propelling these advancements.

Patient-Centric Approaches

Colombia places a strong emphasis on patient-centricity in clinical trials, aiming to enhance participant experiences and promote inclusivity. Efforts are underway to simplify trial protocols, increase patient engagement, and improve access to clinical trials for underrepresented populations.

Collaborative initiatives between research institutions, pharmaceutical companies, and patient advocacy groups have led to the development of patient-centered trial designs, ensuring participant needs are effectively addressed. This patient-centric approach not only benefits Colombian patients but also contributes to generating diverse and representative data for global clinical studies.

By involving patients in the trial process and considering their perspectives, researchers gain valuable insights that inform the development of more effective and patient-friendly treatments.

Regulatory Reforms and Streamlined Processes

Colombia has implemented significant regulatory reforms to streamline the clinical trial process, making it more efficient and attractive for researchers. The National Food and Drug Surveillance Institute (INVIMA) has implemented measures to expedite trial approvals, reducing administrative burdens while maintaining rigorous safety standards.

Furthermore, regulatory authorities have embraced digital solutions, promoting the use of electronic documentation, data management systems, and remote monitoring, which enhance efficiency, data accuracy, and real-time analysis.

These reforms have positioned Colombia as an attractive destination for clinical trials, enabling researchers to conduct studies more effectively, leading to accelerated medical breakthroughs and improved patient care.

Innovative Clinical Trials in Colombia

Innovative Clinical Trials in Colombia

Innovative Clinical Trials in Colombia

Collaborations and International Investments

Colombia’s clinical trial ecosystem thrives on collaborations and international investments. Renowned research institutions, pharmaceutical companies, and contract research organizations (CROs) have established partnerships with Colombian counterparts, fostering knowledge exchange, capacity building, and infrastructure development.

These collaborations enhance Colombia’s clinical trial capabilities, enabling the country to conduct complex trials and attract top-tier researchers. International investments fuel the development of state-of-the-art clinical trial facilities and technology infrastructure, further bolstering Colombia’s position as a preferred destination for cutting-edge research.

The exchange of expertise and resources between international and Colombian stakeholders leads to the discovery of innovative therapies, expanded treatment options, and improved healthcare outcomes for patients both within Colombia and around the world.

Accessible and Diverse Patient Pool

Colombia’s diverse population, with its rich cultural heritage and varied socioeconomic backgrounds, offers a unique advantage for clinical trials. With approximately 50 million people, including diverse ethnic groups, Colombia provides researchers with access to a wide range of patients, enabling comprehensive evaluations of treatment efficacy, safety, and patient responses.

This diversity enhances the generalizability of trial results and ensures that interventions are tailored to meet the needs of a global patient population. Furthermore, Colombia’s universal healthcare system ensures that a significant portion of the population has access to healthcare services, facilitating patient recruitment and participation in clinical trials.

The combination of a diverse patient pool and accessible healthcare contributes to the robustness and representativeness of clinical trial data generated in Colombia.

Government Support and Funding

The Colombian government recognizes the importance of promoting innovative clinical trials and has implemented supportive policies and funding initiatives. Entities such as Colciencias (Administrative Department of Science, Technology, and Innovation) and the Ministry of Health provide grants, incentives, and research funding to researchers and institutions engaged in clinical trials.

These investments aim to foster scientific excellence, attract top-tier researchers, and drive advancements in healthcare. The government’s commitment to supporting clinical trials has resulted in increased collaboration between academia, industry, and government entities, further strengthening Colombia’s position as a hub for cutting-edge research.

By providing financial support and creating an enabling environment, the government ensures that researchers have the necessary resources to conduct innovative trials and contribute to the global body of medical knowledge.

Data Privacy and Ethical Considerations

Colombia places great importance on protecting patient privacy and upholding ethical standards in clinical trials. Researchers and institutions must adhere to strict regulations and guidelines established by ethical review boards and regulatory bodies, such as INVIMA.

These regulations ensure that patient confidentiality and data privacy are maintained throughout the trial process. Informed consent is a critical component, with participants provided with comprehensive information about the trial and their rights as participants. Ethical considerations also include regular monitoring of trial procedures to safeguard participant well-being and ensure adherence to the highest ethical standards.

Colombia’s commitment to ethical practices and data privacy safeguards instills trust in both participants and the scientific community, reinforcing the credibility and reliability of clinical trial results.


Innovative clinical trials in Colombia have positioned the country as a frontrunner in medical research, driving advancements in healthcare and offering new treatment possibilities for patients.

With advancements in various therapeutic areas, patient-centric approaches, streamlined processes, international collaborations, government support, and a diverse patient pool, Colombia is revolutionizing clinical research. The commitment to scientific excellence, ethical considerations, and data privacy ensures the generation of reliable and impactful results.

Colombia’s contributions to global healthcare through innovative clinical trials hold the potential to shape the future of medicine, improving the lives of patients worldwide and offering hope for better health outcomes.

Innovative Clinical Trials in Colombia

Source: Pro Colombia

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Innovative Clinical Trials in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Innovative Clinical Trials in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Innovative Clinical Trials in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Innovative Clinical Trials in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Innovative Clinical Trials in Colombia

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Innovative Clinical Trials in Colombia

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Innovative Clinical Trials in Colombia

The Cohortias Team

Innovative Clinical Trials in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Innovative Clinical Trials in Colombia

Network & Partnerships